Study details
Enrolling now
Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder
Yale University
NCT IDNCT06142955ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 2.7 years
Ages
18–40
Locations
1 site in CT
About this study
Researchers are testing if a treatment called TMS can help with depression in people who have autism. The treatment uses a device that sends magnetic pulses to the brain. The trial will measure changes in behavior and brain activity before and after the treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use MAGSTIM Rapid2 TMS system
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Devices
therapeutic
Body systems
Psychiatry / Mental Health